Home » REPORTS BIGGER 4Q LOSS
REPORTS BIGGER 4Q LOSS
Biotech firm Sunesis Pharmaceuticals Inc. on Friday reported a wider loss for the fourth
quarter, despite higher revenue. Sunesis reported a loss after preferred dividends
of $5.3 million, or 25 cents per share, compared with $4 million, or $2.94 per
share, in the prior year.
MSN
Money
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May